Clinical Roundtable Monograph
نویسندگان
چکیده
Acute myelogenous leukemia (AML), although a relatively rare cancer, is the most common form of acute leukemia to occur in adults. The diagnosis and treatment of patients with AML has traditionally been based on cytogenetic prognostic markers. However, significant advancements in the discovery of the numerous molecular, cytogenetic, and biologic factors affecting this disease have revealed clear patient subgroups who respond uniquely to therapy. Achieving the best response to current and emerging therapies is dependent on understanding how each of these patient subgroups responds to each intervention. This monograph details the current and emerging treatment strategies available for adult patients with AML. Included are discussions of specific patient subgroups, as well as novel therapeutic agents under investigation in this disease. S u p p o r t e d t h r o u g h a n e d u c a t i o n a l g r a n t f r o m G e n z y m e C o r p o r a t i o n A CME Activity
منابع مشابه
Clinical roundtable monograph. Early death in patients with acute promyelocytic leukemia.
With the introduction of all-trans retinoic acid (ATRA) and arsenic trioxide, acute promyelocytic leukemia (APL) has become a highly curable malignancy. Approximately 90% of patients achieve complete remission with induction, which generally includes ATRA and an anthracycline-based chemotherapy. Early death, either before treatment is initiated or during induction, has emerged as one of the mos...
متن کاملClinical roundtable monograph. New alternatives in CLL therapy: managing adverse events.
Chronic lymphocytic leukemia (CLL) is a B-cell leukemia mainly affecting older adults. Historically, CLL has been regarded as an incurable disease, and treatment has been confined to cytotoxic chemotherapy regimens. However, prognosis for patients treated with these agents remained poor, prompting the development of new, targeted agents. The introduction of rituximab, a CD20-targeted monoclonal...
متن کاملClinical Roundtable Monograph Discussants
Antibody-drug conjugates (ADCs) combine cytotoxic chemotherapy and antibody specificity. There are 4 components of ADC technology: the cancer, or target, antigen; the antibody to that target; the linker that connects the drug to the antibody; and the drug itself. The antibody directs the cytotoxic agent to the tumor cell, thereby diminishing the side effect profile of the cytotoxic agent and en...
متن کاملClinical Roundtable Monograph
Ovarian cancer is a relatively infrequent malignancy, but it is the fifth leading cause of cancer-related mortality in American women. The initial diagnosis of ovarian cancer is usually made when the disease is at an advanced stage. Although advanced ovarian cancer is characteristically sensitive to initial surgical debulking followed by platinum-based combination chemotherapy, it is rarely cur...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2013